Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-11-20 Capital/Financing Update
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
BIOERA SPA - Conversione di n. 2 obbligazioni convertibili
Capital/Financing Update Classification · 1% confidence The document is an official communication (Informazione Regolamentata n. 0771-81-2023) from BIOERA S.p.A. regarding the conversion of convertible bonds into new shares. The subject explicitly states: "BIOERA SPA - Conversione di n. 2 obbligazioni convertibili". This action directly relates to changes in the company's capital structure and financing agreements, specifically the conversion of debt into equity. This falls under the definition of Capital/Financing Update (CAP), which covers fundraising, financing activities, or capital structure changes. Although it results in a share issue, the primary event being announced is the execution of a financing term (bond conversion), making CAP more specific than SHA (Share Issue/Capital Change) or POS (Transaction in Own Shares). It is not a general earnings release (ER) or a comprehensive quarterly report (IR).
2023-11-20 Italian
BIOERA SPA - Variazione Capitale Sociale
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from BIOERA S.p.A. titled "Comunicazione di variazione del capitale sociale depositato al competente Registro delle Imprese di Milano-Monza-Brianza-Lodi" (Communication of change in share capital filed with the competent Business Register of Milan-Monza-Brianza-Lodi). It details the increase in the number of ordinary shares following the conversion of convertible bonds and presents the new share capital structure. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition of 'Share Issue/Capital Change' (Code: SHA). Although it mentions filing with the Business Register, the core content is the capital change itself, not just an announcement of a report (RPA/RNS).
2023-11-16 Italian
BIOERA SPA - Conversione di n. 2 obbligazioni convertibili
Capital/Financing Update Classification · 1% confidence The document is a formal communication from BIOERA S.p.A. titled 'Conversione di n.2 obbligazioni convertibili...' (Conversion of n.2 convertible bonds...). It details a specific financing/capital structure event where convertible bonds held by Golden Eagle Capital Advisors, Inc. are being converted into new ordinary shares. This action directly relates to the company's capital structure and fundraising activities. Based on the definitions, the most appropriate category is 'Capital/Financing Update' (CAP), as it describes the mechanics and outcome of a convertible debt instrument being converted into equity. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific announcement about a change in capital structure resulting from a financing agreement, fitting best under CAP.
2023-11-07 Italian
BIOERA SPA - Dimissioni di un Consigliere di Amministrazione
Board/Management Information Classification · 1% confidence The document is an official regulatory announcement (Informazione Regolamentata n. 0771-78-2023) from BIOERA SPA, dated November 3, 2023. The subject ('Oggetto') explicitly states: 'BIOERA SPA - Dimissioni di un Consigliere di Amministrazione' (Resignation of a Board Member). The text confirms the immediate resignation of Dr. Domenico Torchia from his position as a non-executive and independent director. This directly corresponds to the definition of Board/Management Information.
2023-11-03 Italian
BIOERA SPA - Informativa POC Ottobre 2023
Capital/Financing Update Classification · 1% confidence The document is titled "Informativa mensile al 31 ottobre 2023" (Monthly Information as of October 31, 2023) and relates to capital strengthening operations (Prestito obbligazionario convertibile - convertible bond loan) and subsequent conversions. It provides detailed tables showing the status of subscriptions and conversions up to October 2023. This structure—a detailed periodic report on financing/capital structure changes, often mandated by regulators like CONSOB (mentioned in the text) for ongoing capital operations—fits best under Capital/Financing Update (CAP) or potentially Interim/Quarterly Report (IR) if it were a full financial statement. However, since the core focus is tracking the mechanics and status of a specific financing instrument (convertible bond) and its impact on capital, 'CAP' is the most precise fit. It is not a general Earnings Release (ER) or a full Annual Report (10-K). Given the specific nature of tracking capital structure changes related to a financing agreement, CAP is selected.
2023-11-02 Italian
BIOERA SPA- Informativa al mercato ex TUF al 30.09.2023
Regulatory Filings Classification · 1% confidence The document is a monthly financial disclosure provided by Bioera S.p.A. in response to a specific request from the Italian regulator (Consob) under Article 114, paragraph 5, of the TUF (Testo Unico della Finanza). It contains detailed financial tables regarding net financial debt, overdue debt positions, and information on convertible bonds. While it contains financial data, it is a recurring regulatory disclosure mandated by the regulator rather than a standard quarterly or annual financial report (10-K or IR). Given the nature of these specific regulatory disclosures in the Italian market, 'RNS' (Regulatory Filings) is the most appropriate classification as it serves as a general regulatory announcement for compliance purposes. 9M 2023
2023-10-31 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.